China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Role of Radiotherapy in T1-T2N0M0 Glottic Carcinoma With Poor Differentiation: A Prospective Multicenter Phase II Clinical Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132365
Registration Time: 2026/09/14
Type: Interventional study
Primary Sponsor: The Second Affiliated Hospital, Zhejiang University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341319
Published by HT Digital Content Services with permission from Health Daily Digest....